Cipla Health (CHL), a consumer healthcare company in India, has recently expanded its personal care portfolio through the acquisition of Ivia Beaute’s cosmetics and personal care business. This strategic move includes the purchase of Ivia Beaute’s popular brands Astaberry, Ikin, and Bhimsaini, for a reported price of Rs 130 crore, equivalent to approximately US$15.5 million.
The acquisition involves Cipla’s subsidiary acquiring Ivia’s global distribution and marketing business for these beauty products. By venturing into the cosmetics and personal care sector, Cipla aims to enhance its consumer healthcare and wellness portfolio while complementing its existing offerings in skincare.
The company flags its “strong offline and online distribution muscle” and consumer insights engine that has accelerated over 20 brands within its portfolio across key categories.
These categories include topical antiseptics (Cipladine), antifungal solutions (Clocip), feminine and child hygiene products (Mamaxpert and Evexpert) and skin and hair care (Cetafresh, Rivela and Tugain).
“Most of these brands have attained leadership positions in their respective categories,” claims CHL.
Shivam Puri, the CEO and whole-time director of CHL, explains that the target consumer base for their personal care brands is discerning and seeks variety, particularly when it comes to new brands. By adding Astaberry, Ikin, and Bhimsaini to their product lineup, Cipla endeavors to cater to the preferences of these consumers and capture the market demand for premium and trendy beauty products in India.
Cipla recognizes the significance of the Indian market and its growing adoption of beauty and personal care products. The company views the market as crucial for its expansion efforts in the beauty sector. Leveraging its strong presence in Tier 2–6 towns across India, Cipla aims to capitalize on the nation’s fast-growing beauty and personal care sector. This expansion opportunity aligns with the company’s overall strategy of catering to the diverse everyday needs of consumers.
